Prosthetic Aortic Valves: Challenges and Solutions.

[en] Aortic Valve Disease (AVD) is the most common Valvular Heart Disease (VHD), affecting millions of people worldwide. Severe AVD is treated in most cases with prosthetic aortic valve replacement, which involves the substitution of the native aortic valve with a prosthetic one. In this review we will discuss the different types of prosthetic aortic valves available for implantation and the challenges faced by patients, medical doctors, researchers and manufacturers, as well as the approaches that are taken to overcome them.

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Musumeci, Lucia ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > GIGA-R : GIGA - Cardiovascular Sciences

Jacques, Nicolas

Hego, Alexandre

Nchimi Longang, Alain ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation

Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation

Oury, Cécile ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > GIGA-R : GIGA - Cardiovascular Sciences

Language :

English

Title :

Prosthetic Aortic Valves: Challenges and Solutions.

Publication date :

2018

Journal title :

Frontiers in Cardiovascular Medicine

eISSN :

2297-055X

Publisher :

Frontiers Research Foundation, Lausanne, Switzerland

Volume :

Pages :

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 21 June 2018

Statistics

Number of views

142 (10 by ULiège)

Number of downloads

118 (2 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Søndergaard L, Saraste A, Christersson C, Vahanian A, Dangas GD, Weitz JI. The year in cardiology 2017: valvular heart disease. Eur Heart J (2018) 39(8):650–7. 10.1093/eurheartj/ehx772
Dangas GD, Weitz JI, Giustino G, Makkar R, Mehran R. Prosthetic heart valve thrombosis. J Am Coll Cardiol (2016) 68(24):2670–89. 10.1016/j.jacc.2016.09.958
Baumgartner H, Falk V, Bax JJ, de Bonis M, Hamm C, Holm PJ. Valvular heart disease Supplement to 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J (2017) 38(36):2739–91.
Butcher JT, Mahler GJ, Hockaday LA. Aortic valve disease and treatment: the need for naturally engineered solutions. Adv Drug Deliv Rev (2011) 63(4-5):242–68. 10.1016/j.addr.2011.01.008
Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro heart survey on valvular heart disease. Eur Heart J (2003) 24(13):1231–43. 10.1016/S0195-668X(03)00201-X
Deeb GM, Reardon MJ, Chetcuti S, Patel HJ, Grossman PM, Yakubov SJ, et al. 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. J Am Coll Cardiol (2016) 67(22):2565–74. 10.1016/j.jacc.2016.03.506
Conte JV, Hermiller J, Resar JR, Deeb GM, Gleason TG, Adams DH, et al. Complications after self-expanding transcatheter or surgical aortic valve replacement. Semin Thorac Cardiovasc Surg (2017) 29(3):321–30. 10.1053/j.semtcvs.2017.06.001
Lindman BR, Clavel M-A, Mathieu P, Iung B, Lancellotti P, Otto CM, et al. Calcific aortic stenosis. Nat Rev Dis Primers (2016) 124(2):16006. 10.1038/nrdp.2016.6
Goldbarg SH, Elmariah S, Miller MA, Fuster V. Insights into degenerative aortic valve disease. J Am Coll Cardiol (2007) 50(13):1205–13. 10.1016/j.jacc.2007.06.024
Yacoub MH, Takkenberg JJ. Will heart valve tissue engineering change the world? Nat Clin Pract Cardiovasc Med (2005) 2(2):60–1. 10.1038/ncpcardio0112
Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 363(17):1597–607. 10.1056/NEJMoa1008232
Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleiman NS, Heimansohn D, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol (2014) 63(19):1972–81. 10.1016/j.jacc.2014.02.556
Cribier A. The development of transcatheter aortic valve replacement (TAVR). Glob Cardiol Sci Pract (2016) 30(4):e201632.
Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med (2016) 374(17):1609–20. 10.1056/NEJMoa1514616
Arora S, Vavalle JP. Transcatheter aortic valve replacement in intermediate and low risk patients-clinical evidence. Ann Cardiothorac Surg (2017) 6(5):493–7. 10.21037/acs.2017.07.01
Vlastra W, Piek JJ, Delewi R. The current status of antiplatelet therapy in patients undergoing transcatheter aortic valve implantation. J Thorac Dis (2017) 9(10):3652–5. 10.21037/jtd.2017.09.118
Head SJ, Çelik M, Kappetein AP. Mechanical versus bioprosthetic aortic valve replacement. Eur Heart J (2017) 38(28):2183–91. 10.1093/eurheartj/ehx141
Pibarot P, Dumesnil JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation (2009) 119(7):1034–48. 10.1161/CIRCULATIONAHA.108.778886
Rodriguez-Gabella T, Voisine P, Puri R, Pibarot P, Rodés-Cabau J. Aortic bioprosthetic valve durability: incidence, mechanisms, predictors, and management of surgical and transcatheter valve degeneration. J Am Coll Cardiol (2017) 70(8):1013–28. 10.1016/j.jacc.2017.07.715
Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J (2017) 38(36):2739–91. 10.1093/eurheartj/ehx391
Scotten LN, Siegel R. Thrombogenic potential of transcatheter aortic valve implantation with trivial paravalvular leakage. Ann Transl Med (2014) 2(5):43. 10.3978/j.issn.2305-5839.2014.05.04
Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood (2014) 123(18):2768–76. 10.1182/blood-2013-10-463646
Simionescu DT. Prevention of calcification in bioprosthetic heart valves: challenges and perspectives. Expert Opin Biol Ther (2004) 4(12):1971–85. 10.1517/14712598.4.12.1971
Schoen FJ. Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering. Circulation (2008) 118(18):1864–80. 10.1161/CIRCULATIONAHA.108.805911
Arsalan M, Walther T. Durability of prostheses for transcatheter aortic valve implantation. Nat Rev Cardiol (2016) 13(6):360–7. 10.1038/nrcardio.2016.43
Fraser AG, Daubert JC, Van de Werf F, Estes NA, Smith SC, Krucoff MW, et al. Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. Report of a policy conference of the European Society of Cardiology. Eur Heart J (2011) 32(13):1673–86. 10.1093/eurheartj/ehr171
Riool M, de Breij A, Drijfhout JW, Nibbering PH, Zaat SAJ. Antimicrobial peptides in biomedical device manufacturing. Front Chem (2017) 5(5):63. 10.3389/fchem.2017.00063
Ramasamy M, Lee J. Recent nanotechnology approaches for prevention and treatment of biofilm-associated infections on medical devices. Biomed Res Int (2016) 2016:1–17. 10.1155/2016/1851242
Jorge-Herrero E, Garcia Paez JM, del Castillo-Olivares Ramos JL. Tissue heart valve mineralization: Review of calcification mechanisms and strategies for prevention. J Appl Biomater Biomech (2005) 3(2):67–82.
Mahjoub H, Mathieu P, Sénéchal M, Larose E, Dumesnil J, Després JP, et al. ApoB/ApoA-I ratio is associated with increased risk of bioprosthetic valve degeneration. J Am Coll Cardiol (2013) 61(7):752–61. 10.1016/j.jacc.2012.11.033
Mahmut A, Mahjoub H, Boulanger MC, Fournier D, Després JP, Pibarot P, et al. Lp-PLA2 is associated with structural valve degeneration of bioprostheses. Eur J Clin Invest (2014) 44(2):136–45. 10.1111/eci.12199
Nsaibia MJ, Mahmut A, Mahjoub H, Dahou A, Bouchareb R, Boulanger MC, et al. Association between plasma lipoprotein levels and bioprosthetic valve structural degeneration. Heart (2016) 102(23):1915–21. 10.1136/heartjnl-2016-309541
Chester AH, El-Hamamsy I, Butcher JT, Latif N, Bertazzo S, Yacoub MH. The living aortic valve: From molecules to function. Global Cardiology Science and Practice (2014) 2014(1):11–77. 10.5339/gcsp.2014.11
Yacoub MH. In Search of Living Valve Substitutes. J Am Coll Cardiol (2015) 66(8):889–91. 10.1016/j.jacc.2015.07.007
Claiborne TE, Slepian MJ, Hossainy S, Bluestein D. Polymeric trileaflet prosthetic heart valves: evolution and path to clinical reality. Expert Rev Med Devices (2012) 9(6):577–94. 10.1586/erd.12.51
Hockaday LA, Kang KH, Colangelo NW, Cheung PY, Duan B, Malone E, et al. Rapid 3D printing of anatomically accurate and mechanically heterogeneous aortic valve hydrogel scaffolds. Biofabrication (2012) 4(3):035005. 10.1088/1758-5082/4/3/035005